A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways.
about
Combined effects of chronic nicotine and acute virus exposure on neurotrophin expression in rat lungExaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats.Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae.An update on respiratory syncytial virus antiviral agents.Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link.Palivizumab in the prevention of respiratory syncytial virus disease.An epidemiological study of respiratory syncytial virus associated hospitalizations in DenmarkPalivizumab in the prophylaxis of respiratory syncytial virus infection.Prevalence of Acute Lower Respiratory Tract Infections due to Respiratory Syncytial Virus in Amirkola Children's hospital, Northern Iran during March 2008-March 2010Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.The relationship between early respiratory viral infections and subsequent wheezing and asthma.Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis.Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV modelRespiratory syncytial virus prevention and therapy: past, present, and future.Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential.Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection.Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells.Leukotrienes mediate neurogenic inflammation in lungs of young rats infected with respiratory syncytial virus.Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats.
P2860
Q28564506-5FA77186-1B34-49A8-AF7D-7E3413726AE7Q33931486-3B285B73-DEFA-4335-B488-A786B78B16D6Q33938539-4700B56A-B09B-4F86-81E6-7300A1A1700FQ34141078-9EEDBBE0-4EDB-4C07-9D51-5752BBB97D60Q34740826-9A16FBCE-FA94-4C2B-BA51-26BBBD3CAB17Q34974757-F80BDBC8-659A-4167-A56C-BE63994AF95FQ35786132-1429EA9E-F77A-4BAD-AECA-D6B3D5D6813FQ36278040-CD13167F-3123-4906-8DDB-1C1461E5C983Q36458000-3148E474-DEF5-4BDF-8F2E-FFF9CEE0D510Q36803900-7E90692B-1B51-4F17-9036-39129C112FF0Q36843675-6AB5B011-5998-4DCC-8E3C-08BC90EC988CQ37711931-5A26AA84-30A0-42B7-A713-9681D79AB4CBQ37733544-32D68A34-3E0A-451F-807A-E59024B09627Q37857806-0E3B5E46-FACA-400C-826B-4D1D5D4D636EQ37929687-E0905833-9335-4F92-BDC4-AF0B0BC2BE47Q38671952-4CA66C32-54D5-438D-9C88-F6F5967D546EQ38945689-B508EEEF-D7DF-465E-90D2-3BAC45864029Q40074629-379DF6BA-7AC1-4467-BE44-57A0BEDEDE09Q43954408-3D192814-E6E8-42EC-B435-85AE3BEE3AC4Q45700451-92075F6B-C079-4B4C-A0B4-CC000E34D28B
P2860
A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
A humanized monoclonal antibod ...... d inflammation in rat airways.
@en
type
label
A humanized monoclonal antibod ...... d inflammation in rat airways.
@en
prefLabel
A humanized monoclonal antibod ...... d inflammation in rat airways.
@en
P2093
P2860
P1433
P1476
A humanized monoclonal antibod ...... d inflammation in rat airways.
@en
P2093
Bertrand PJ
Holmgren NL
Piedimonte G
Rodriguez MM
P2860
P304
P356
10.1203/00006450-200003000-00011
P407
P577
2000-03-01T00:00:00Z
P6179
1064217219